Los nuevos medicamentos para la diabetes podrían no ser tan efectivos en pacientes afroamericanos
LUNES, 25 de septiembre de 2023 (HealthDay News) – Una nueva investigación sugiere que algunos tratamientos nuevos para la diabetes podrían no ser tan beneficiosos para los pacientes afroamericanos, después de que ensayos anteriores de medicamentos in…
Learn MoreOzempic: What It Is, Uses, Side Effects & Drug Interactions
Ozempic (semaglutide) is an injectable, prescription-only medication that suppresses appetite and slows down digestion.Here, you will learn more about Ozempic, what it is, what it’s used for, how it works, side effects, drug interactions, foods to avo…
Learn MoreNewer Diabetes Meds Might Not Work as Well in Black Patients
FRIDAY, Sept. 22, 2023 (HealthDay News) – New research suggests some newer diabetes treatments may not be as beneficial for Black patients, after earlier drug trials included small numbers of non-white people.Whether the medications — called sodium-g…
Learn MoreNewer Diabetes Meds Might Not Work as Well in Black Patients
FRIDAY, Sept. 22, 2023 (HealthDay News) – New research suggests some newer diabetes treatments may not be as beneficial for Black patients, after earlier drug trials included small numbers of non-white people.Whether the medications — called sodium-g…
Learn MoreDiabetes Drug Maker Sues Over Compounded Versions of Mounjaro
WEDNESDAY, Sept. 20, 2023 (HealthDay News) — Another diabetes drug maker is taking legal action against businesses in several states, alleging that they’re “fraudulently claiming” that their compounded products are the same as its medication.This tim…
Learn MoreEn medio de la escasez, el fabricante de Wegovy anuncia que las restricciones continuarán hasta 2024
VIERNES, 11 de agosto de 2023 (HealthDay News) — Mientras la demanda del popularísimo medicamento para perder peso Wegovy continúa en aumento, el fabricante del fármaco, Novo Nordis, anunció el jueves que continuará con las restricciones de las dosis…
Learn MoreAmid Shortages, Maker Says Restrictions on Wegovy Will Continue Into 2024
FRIDAY, Aug. 11, 2023 (HealthDay News) – As demand for the wildly popular weight-loss drug Wegovy continues to climb, drug maker Novo Nordisk said Thursday that it will continue restrictions on starter doses of the medication into 2024.The new plan ex…
Learn More¿Podría la metformina ayudar a los adultos mayores a recuperarse de una cirugía?
VIERNES, 28 de julio de 2023 (HealthDay News) — La metformina, un medicamento para la diabetes, también podría beneficiar a los pacientes mayores tras una cirugía o enfermedad, sugiere un pequeño estudio. Los investigadores encontraron que la metform…
Learn MoreCould Metformin Help Seniors Bounce Back After Surgery?
FRIDAY, July 28, 2023 (HealthDay News) — The diabetes drug metformin might also benefit older patients after an injury or illness, a small study suggests.Researchers found that metformin — a drug that has been around for more than a half-century to …
Learn MoreUna inyección semanal de insulina podría cambiarlo todo en la diabetes tipo 2
LUNES, 17 de julio de 2023 (HealthDay News) — Las personas con diabetes tipo 2 quizá pronto tengan acceso a unas cómodas inyecciones semanales de insulina, que podrían reemplazar a las inyecciones diarias que se requieren ahora. Una formulación de in…
Learn More